封面
市场调查报告书
商品编码
1684318

药物整合聚合物纤维市场,按类型、按应用、按治疗适应症、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Drug Integrated Polymer Fibers Market, By Type, By Application, By Therapeutic Indication, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年药物整合聚合物纤维市场价值为 8,598 万美元,2025 年至 2032 年期间复合年增长率为 5.90%。

药物整合聚合物纤维市场-市场动态

个人化医疗需求的不断增长预计将推动市场成长。

个人化医疗透过针对个别患者的针对性治疗彻底改变了药物传递方式,进而促进了基于聚合物的药物输送系统的使用。含有药物的聚合物纤维能够控制并持续释放药物,从而确保根据每位患者的独特需求优化治疗效果。 2023年,FDA批准了16种针对罕见疾病患者的新型个人化治疗方法,较2022年的6种核准有大幅增加。儘管如此,纤维製造技术的进步可能为市场带来成长机会。相反,高昂的製造成本可能会阻碍市场扩张。

药物整合聚合物纤维市场-关键见解

根据我们的研究分析师的分析,预测期内(2025-2032 年),全球市场预计年复合成长率约为 5.90%

根据类型细分,预计聚乳酸 (PLA) 将在 2024 年占据最大市场份额

根据应用细分,骨科缝合线是 2024 年的主要应用

从地区来看,北美是 2024 年的主要收入来源

药物整合聚合物纤维市场-細項分析:

全球药物整合聚合物纤维市场根据类型、应用、治疗指征、最终用户和地区进行细分。

根据类型,市场分为三类:聚乳酸 (PLA)、聚二氧化酮 (PDO)、聚己内酯 (PCL) 和其他 (PGA、PLGA 和 PDLL)。聚乳酸(PLA)引领市场。聚乳酸 (PLA) 是一种可生物降解且生物相容性的聚合物,由于其可加工成纤维、薄膜和其他形式以控製药物释放,因此经常用于该市场。 PLA 源自玉米淀粉或甘蔗等可再生资源,是一种环保选择。它的生物降解性使得纤维在体内逐渐分解,从而最大限度地减少了手术切除的需要。

根据应用,市场分为五类:药物传递、骨科缝合线、血管支架、血管移植、皮肤伤口癒合等。骨科缝合线占据市场主导地位。骨科缝合线中的药物整合聚合物纤维市场代表​​了医疗器材产业中一个前景光明且快速发展的领域,它结合了聚合物纤维的生物相容性与骨科应用中有效和局部药物传递的需求。由药物整合聚合物纤维製成的骨科缝合线旨在透过将药物直接输送到手术部位来促进癒合。这在骨科手术中尤其重要,因为骨骼和软组织的正确癒合对于长期復原至关重要。

根据治疗适应症,市场分为三类:癌症、心血管疾病和呼吸系统疾病。随着技术的进步,这些纤维将变得更加复杂,可以更好地控制药物释放和个人化的治疗方法,最终改善患者的治疗效果和生活品质。在这些治疗领域使用聚合物纤维进行药物传递的最显着优势之一是能够提供局部和有针对性的治疗,最大限度地减少全身副作用。药物整合聚合物纤维的开发必须满足严格的监管要求,特别是在生物相容性、安全性和长期疗效方面。

根据最终用户,市场分为两类:製药公司和医疗器材製造商。药物整合聚合物纤维市场,特别是从製药公司和医疗器材製造商等最终用户的角度来看,正在经历显着的成长,因为这些行业正在探索先进的药物输送技术,以实现更有效和更有针对性的治疗。这两个行业都在越来越多地利用药物整合聚合物纤维来改善患者治疗效果并优化治疗方案。

药物整合聚合物纤维市场-地理洞察

北美引领市场扩张,主要受新兴经济体医疗保健支出不断增加的推动。政府和私营部门对医疗基础设施和医学研究的资金增加促进了药物整合聚合物纤维的进步和实施。根据美国医学会报道,2022年美国医疗支出成长4.1%,达到4.5兆美元,相当于每人1,3493美元。这一增长率与疫情前的数据一致,具体为 2019 年的 4.1%。由于奈米技术和静电纺丝技术的投资不断增加,欧洲成为市场成长第二大地区。

药物整合聚合物纤维市场-竞争格局:

药物整合聚合物纤维市场竞争激烈,特色是众多知名企业争相透过创造创新产品和先进的药物输送系统来抢占市场份额。由于对有针对性的药物输送机制、微创医疗设备和生物相容性材料的需求不断增长,该市场正在经历成长。该领域的公司致力于开发能够持续释放药物同时确保药物的生物相容性和功效的先进聚合物纤维。此外,这些公司正在与製药组织、生技公司和学术机构建立合作关係,以加强其产品开发并获得最先进的技术。

最新动态:

2024 年 6 月 25 日,包括药膏和注射器在内的医疗产品在提供局部药物传输方面遇到了挑战,尤其是在长时间内以受控的方式输送药物。为了解决这个问题,Empa 的研究人员正在创新聚合物纤维,旨在长时间精确地输送活性成分。这些液芯纤维封装了药物,可以整合到医用纺织品中。

目录

第 1 章:药物整合聚合物纤维市场概述

  • 研究范围
  • 市场估计年限

第 2 章:执行摘要

  • 市场片段
    • 药物整合聚合物纤维市场按类型细分
    • 药物整合聚合物纤维市场片段(按应用)
    • 药物整合聚合物纤维市场片段(按治疗适应症)
    • 药物整合聚合物纤维市场片段(按最终用户)
    • 药物整合聚合物纤维市场(按国家/地区)摘要
    • 药物整合聚合物纤维市场按地区细分
  • 竞争洞察

第 3 章:药物整合聚合物纤维关键市场趋势

  • 药物整合聚合物纤维市场驱动因素
    • 市场驱动因素的影响分析
  • 药物整合聚合物纤维市场限制
    • 市场限制的影响分析
  • 药物整合聚合物纤维市场机会
  • 药物整合聚合物纤维市场未来趋势

第四章:药物整合聚合物纤维产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章:药物整合聚合物纤维市场:地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章:药物整合聚合物纤维市场格局

  • 药物整合聚合物纤维市场份额分析,2024 年
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章:药物整合聚合物纤维市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 聚乳酸(PLA)
    • 聚二氧化酮 (PDO)
    • 聚己内酯(PCL)
    • 其他(PGA、PLGA 和 PDLL)

第 8 章:药物整合聚合物纤维市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 药物输送
    • 骨科缝合线
    • 血管支架
    • 血管移植
    • 皮肤伤口癒合
    • 其他的

第九章:药物整合聚合物纤维市场 - 按治疗适应症

  • 概述
    • 按治疗适应症分類的细分市场份额分析
    • 癌症
    • 心血管疾病
    • 呼吸系统疾病

第 10 章:药物整合聚合物纤维市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 医疗器材製造商

第 11 章:药物整合聚合物纤维市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美药物整合聚合物纤维主要製造商
    • 北美市场规模及预测(按国家/地区)
    • 北美市场规模和预测(按类型)
    • 北美市场规模与预测,按应用划分
    • 北美市场规模及预测(依治疗适应症划分)
    • 北美市场规模及预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲药物整合聚合物纤维主要製造商
    • 欧洲市场规模及预测(按国家)
    • 欧洲市场规模与预测(按类型)
    • 欧洲市场规模和预测,按应用
    • 欧洲市场规模及预测(依治疗适应症划分)
    • 欧洲市场规模及预测(按最终用户)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区药物整合聚合物纤维主要製造商
    • 亚太地区市场规模及预测(依国家/地区划分)
    • 亚太地区市场规模及预测(按类型)
    • 亚太地区市场规模及预测(按应用划分)
    • 亚太地区市场规模及预测(依治疗适应症划分)
    • 亚太地区市场规模及预测(依最终用户)
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲药物整合聚合物纤维主要製造商
    • 拉丁美洲市场规模及预测(按国家/地区)
    • 拉丁美洲市场规模及预测(按类型)
    • 拉丁美洲市场规模及预测(按应用划分)
    • 拉丁美洲市场规模及预测(依治疗适应症划分)
    • 拉丁美洲市场规模及预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲药物整合聚合物纤维主要製造商
    • MEA 市场规模及预测(依国家/地区划分)
    • MEA 市场规模和预测(按类型)
    • MEA 市场规模及预测(按应用)
    • MEA 市场规模及预测(依治疗适应症划分)
    • MEA 市场规模及预测(依最终用户)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 12 章:关键供应商分析-药物整合聚合物纤维产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Asahi Kasei Corporation
    • Teijin Aramid
    • Toray Industries Inc.
    • Lycra (Invista)
    • Kaneka Corporation
    • Mitsubishi Chemical Corporation
    • Celanese Corporation
    • Teijin Limited
    • DuPont de
    • Nemours Inc.
    • Rhodia (Solvay)
    • Solvay SA
    • BASF SE
    • Sumitomo Chemical Company Limited
    • Evonik Industries AG
    • Kureha Corporation
    • Others

第 13 章:360 度分析师视角

第 14 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4821

REPORT HIGHLIGHT

The Drug Integrated Polymer Fibers Market was valued at US$ 85.98 million in 2024 and expanded at a CAGR of 5.90% from 2025 to 2032.

Drug Integrated Polymer Fibers are advanced fibers composed of polymers that are infused with therapeutic agents to facilitate controlled and sustained drug release. These fibers are engineered to administer medications directly to targeted areas within the body or to distribute them throughout the system over an extended duration, thereby improving the efficacy and accuracy of medical treatments. Their applications are numerous, particularly within the medical and pharmaceutical sectors, where they serve purposes such as implantable drug delivery systems, wound management, and surgical sutures.

Drug Integrated Polymer Fibers Market- Market Dynamics

Rising Demand for Personalized Medicine is expected to the market growth.

Personalized medicine is revolutionizing drug delivery by facilitating targeted treatments that are specific to individual patients, which in turn is promoting the use of polymer-based drug delivery systems. Polymer fibers that incorporate drugs enable the controlled and sustained release of medications, thereby ensuring that therapeutic effects are optimized according to the unique needs of each patient. In 2023, the FDA approved 16 new personalized treatments aimed at patients with rare diseases, a significant increase from the six approvals in 2022. Among the newly approved treatments for 2023, there are seven drugs for cancer and three addressing other diseases and conditions, as reported by the Personalized Medicine Coalition. Nevertheless, advancements in fiber manufacturing technology may present growth opportunities for the market. Conversely, high manufacturing costs could impede market expansion.

Drug Integrated Polymer Fibers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)

Based on Type segmentation, Polylactic Acid (PLA) was predicted to show maximum market share in the year 2024

Based on application segmentation, Orthopedic Sutures was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Drug Integrated Polymer Fibers Market- Segmentation Analysis:

The Global Drug Integrated Polymer Fibers Market is segmented based on Type, Application, Therapeutic Indication, End-User, and Region.

The market is divided into three categories based on Type: Polylactic Acid (PLA), Polydioxanone (PDO), Polycaprolactone (PCL), and Others (PGA, PLGA, and PDLL). Polylactic Acid (PLA) leads the market. Polylactic Acid (PLA), a biodegradable and biocompatible polymer, is frequently used in this market due to its ability to be processed into fibers, films, and other forms for controlled drug release. PLA is derived from renewable resources like cornstarch or sugarcane, making it an eco-friendly choice. Its biodegradability allows for the gradual breakdown of the fibers in the body, minimizing the need for surgical removal.

The market is divided into five categories based on application: Drug Delivery, Orthopedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing, and Others. Orthopedic Sutures dominate the market. The Drug Integrated Polymer Fibers Market in the Context of Orthopedic Sutures represents a promising and rapidly evolving segment within the medical device industry, combining the biocompatibility of polymer fibers with the need for effective and localized drug delivery in orthopedic applications. Orthopedic sutures made from drug-integrated polymer fibers are designed to promote healing by delivering drugs directly to the surgical site. This is particularly important in orthopedic surgeries, where proper healing of bone and soft tissue is critical for long-term recovery.

The market is divided into three categories based on Therapeutic Indications: Cancer, Cardiovascular Diseases, and Respiratory Diseases. As technology advances, these fibers will become more sophisticated, allowing for better-controlled drug release and personalized treatment approaches, ultimately improving patient outcomes and quality of life. One of the most significant advantages of using polymer fibers for drug delivery in these therapeutic areas is the ability to provide localized and targeted treatment, minimizing systemic side effects. The development of drug-integrated polymer fibers must meet rigorous regulatory requirements, particularly regarding biocompatibility, safety, and long-term efficacy.

The market is divided into two categories based on End-User: Pharmaceutical Companies and Medical Device Manufacturers. The Drug Integrated Polymer Fibers Market, particularly from the perspective of end-users like Pharmaceutical Companies and Medical Device Manufacturers, is experiencing significant growth as these sectors explore advanced drug delivery technologies for more effective and targeted therapies. Both industries are increasingly leveraging drug-integrated polymer fibers to improve patient outcomes and optimize treatment regimens.

Drug Integrated Polymer Fibers Market- Geographical Insights

North America leads the market expansion, primarily driven by the increasing healthcare expenditures in emerging economies. The rise in funding from both government and private sectors for healthcare infrastructure and medical research facilitates the advancement and implementation of drug-integrated polymer fibers. As reported by the American Medical Association, health spending in the United States rose by 4.1% in 2022, reaching USD 4.5 trillion, which translates to USD 13,493 per capita. This growth rate aligns with pre-pandemic figures, specifically 4.1% in 2019. While government expenditures aimed at managing the pandemic resulted in significant increases in National Health Expenditure (NHE), these costs saw a notable decline in 2021, coinciding with a resurgence in the utilization of medical goods and services. Europe ranks as the second-largest region for market growth, attributed to the increasing investments in nanotechnology and electrospinning techniques.

Drug Integrated Polymer Fibers Market- Competitive Landscape:

The Drug Integrated Polymer Fibers Market exhibits a high level of competition, characterized by numerous prominent entities striving to capture market share through the creation of innovative products and sophisticated drug delivery systems. This market is experiencing growth driven by the rising demand for targeted drug delivery mechanisms, minimally invasive medical devices, and biocompatible materials. Firms operating in this sector are dedicated to the development of advanced polymer fibers capable of providing sustained drug release while ensuring the biocompatibility and efficacy of pharmaceuticals. Additionally, these companies are establishing collaborations with pharmaceutical organizations, biotechnology firms, and academic institutions to bolster their product development efforts and gain access to state-of-the-art technologies.

Recent Developments:

On June 25, 2024, Medical products, including ointments and syringes, encountered challenges in providing localized medication delivery, particularly in a controlled manner over extended durations. In response to this issue, researchers at Empa are innovating polymer fibers designed to deliver active ingredients with precision over prolonged periods. These liquid core fibers encapsulate pharmaceuticals and can be integrated into medical textiles.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Asahi Kasei Corporation
  • Teijin Aramid
  • Toray Industries Inc.
  • Lycra (Invista)
  • Kaneka Corporation
  • Mitsubishi Chemical Corporation
  • Celanese Corporation
  • Teijin Limited
  • DuPont de
  • Nemours Inc.
  • Rhodia (Solvay)
  • Solvay S.A.
  • BASF SE
  • Sumitomo Chemical Company Limited
  • Evonik Industries AG
  • Kureha Corporation
  • Others

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polylactic Acid (PLA)
  • Polydioxanone (PDO)
  • Polycaprolactone (PCL)
  • Others (PGA, PLGA and PDLL)

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Orthopedic Sutures
  • Vascular Stents
  • Vascular Grafts
  • Dermal Wound Healing
  • Others

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY THERAPEUTIC INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Cardiovascular Diseases
  • Respiratory Diseases

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Medical Device Manufacturers

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Integrated Polymer Fibers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Integrated Polymer Fibers Market Snippet by Type
    • 2.1.2. Drug Integrated Polymer Fibers Market Snippet by Application
    • 2.1.3. Drug Integrated Polymer Fibers Market Snippet by Therapeutic Indication
    • 2.1.4. Drug Integrated Polymer Fibers Market Snippet by End-User
    • 2.1.5. Drug Integrated Polymer Fibers Market Snippet by Country
    • 2.1.6. Drug Integrated Polymer Fibers Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Integrated Polymer Fibers Key Market Trends

  • 3.1. Drug Integrated Polymer Fibers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Integrated Polymer Fibers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Integrated Polymer Fibers Market Opportunities
  • 3.4. Drug Integrated Polymer Fibers Market Future Trends

4. Drug Integrated Polymer Fibers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Integrated Polymer Fibers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Integrated Polymer Fibers Market Landscape

  • 6.1. Drug Integrated Polymer Fibers Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Integrated Polymer Fibers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Polylactic Acid (PLA)
    • 7.1.3. Polydioxanone (PDO)
    • 7.1.4. Polycaprolactone (PCL)
    • 7.1.5. Others (PGA, PLGA and PDLL)

8. Drug Integrated Polymer Fibers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Orthopedic Sutures
    • 8.1.4. Vascular Stents
    • 8.1.5. Vascular Grafts
    • 8.1.6. Dermal Wound Healing
    • 8.1.7. Others

9. Drug Integrated Polymer Fibers Market - By Therapeutic Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Indication, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Respiratory Diseases

10. Drug Integrated Polymer Fibers Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Medical Device Manufacturers

11. Drug Integrated Polymer Fibers Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Drug Integrated Polymer Fibers Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Drug Integrated Polymer Fibers Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Drug Integrated Polymer Fibers Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Drug Integrated Polymer Fibers Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Drug Integrated Polymer Fibers Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Drug Integrated Polymer Fibers Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Asahi Kasei Corporation
    • 12.2.2. Teijin Aramid
    • 12.2.3. Toray Industries Inc.
    • 12.2.4. Lycra (Invista)
    • 12.2.5. Kaneka Corporation
    • 12.2.6. Mitsubishi Chemical Corporation
    • 12.2.7. Celanese Corporation
    • 12.2.8. Teijin Limited
    • 12.2.9. DuPont de
    • 12.2.10. Nemours Inc.
    • 12.2.11. Rhodia (Solvay)
    • 12.2.12. Solvay S.A.
    • 12.2.13. BASF SE
    • 12.2.14. Sumitomo Chemical Company Limited
    • 12.2.15. Evonik Industries AG
    • 12.2.16. Kureha Corporation
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us